Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1980
Metabolic fate of diethylstilbestrol in the Syrian golden hamster, a susceptible species for diethylstilbestrol carcinogenicityR Gottschlich, M Metzler
Expert Opinion on Investigational Drugs|July 2, 2005
Novel developments with selective, non-peptidic kappa-opioid receptor agonistsA Barber, R Gottschlich
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|July 1, 1984
Oxidative metabolites of the teratogen and transplacental carcinogen diethylstilbestrol in the fetal Syrian golden hamsterR Gottschlich, M Metzler
The Journal of Membrane Biology|October 10, 1998
Blood-brain barrier permeation: molecular parameters governing passive diffusionH Fischer, R Gottschlich, A Seelig
Arzneimittel-Forschung|January 1, 1985
[Nitrefazole, a 4-nitroimidazole derivative with a marked inhibitory effect on aldehyde dehydrogenase. Synthesis and structural assignment]R Klink, K G Pachler, R Gottschlich
Proceedings of the National Academy of Sciences of the United States of America|January 4, 1994
A method to determine the ability of drugs to diffuse through the blood-brain barrierA Seelig, R Gottschlich, R M Devant
Chirality|January 1, 1994
kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753R Gottschlich, M Krug, A Barber, et al.
Drugs Under Experimental and Clinical Research|January 1, 1995
The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivityR Gottschlich, A Barber, G D Bartoszyk, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 18, 1999
Effects of GR-89696 and the novel peripherally selective OP2 agonists, EMD-61569 and EMD-61747, against focal cerebral ischemia in the ratA Barber, H M Bender, R Gottschlich, et al.
British Journal of Pharmacology|June 16, 1999
Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drugJ W Jonker, E Wagenaar, L van Deemter, et al.
Pageof 2